We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SOPH market cap is 326.15M. The company's latest EPS is USD -1.1295 and P/E is -4.43.
Quarter End | |
---|---|
USD (US$) | |
Total Revenue | |
Operating Income | |
Net Income |
Year End December 30 2021 | 2021 |
---|---|
USD (US$) | |
Total Revenue | 40.45M |
Operating Income | -71.49M |
Net Income | -73.68M |
Quarter End | |
---|---|
USD (US$) | |
Total Assets | |
Total Liabilities | |
Total Equity |
Year End December 30 2021 | 2021 |
---|---|
USD (US$) | |
Total Assets | 320.17M |
Total Liabilities | 44.77M |
Total Equity | 275.4M |
Market Cap | 326.15M |
Price to Earnings Ratio | -4.43 |
Price to Sales Ratio | 8.06 |
Price to Cash Ratio | 1.69 |
Price to Book Ratio | 1.18 |
Dividend Yield | - |
Shares Outstanding | 65.23M |
Average Volume (1 week) | 29.43k |
Average Volume (1 Month) | 68.36k |
52 Week Change | 6.16% |
52 Week High | 7.37 |
52 Week Low | 2.13 |
Spread (Intraday) | 2.56 (41.03%) |
Company Name | Sophia Genetics SA |
Address |
rue du centre 172 lausanne 1025 |
Website | https://www.sophiagenetics.com |
Industry | cmp processing,data prep svc (7374) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions